We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Arterial Spin Labeling MRI Identifies Evidence of Cognitive Decline Before Symptoms Present

By MedImaging International staff writers
Posted on 16 Oct 2014
Print article
Image:  Brain perfusion: Red indicates low perfusion, yellow indicates high perfusion. Overall, the brain perfusion is similar between all three groups (see article). The most prominent difference is present in the posterior cingulate cortex (indicated by the arrow), a region close to the midline in the superior and posterior part of the brain. Control participants who remain stable have higher perfusion as compared to deteriorating controls and MCI (Photo courtesy of RSNA the Radiological Society of North America).
Image: Brain perfusion: Red indicates low perfusion, yellow indicates high perfusion. Overall, the brain perfusion is similar between all three groups (see article). The most prominent difference is present in the posterior cingulate cortex (indicated by the arrow), a region close to the midline in the superior and posterior part of the brain. Control participants who remain stable have higher perfusion as compared to deteriorating controls and MCI (Photo courtesy of RSNA the Radiological Society of North America).
A type of magnetic resonance imaging (MRI) technology is being used to identify signs of cognitive decline in the brain even before symptoms appear. The technique has the potential to be used as a biomarker in very early diagnosis of preclinical dementia.

The World Health Organization (WHO; Geneva, Switzerland) stated that dementia affects more than 35 million people worldwide, a number expected to more than double by 2030. Problems in the brain related to dementia, such as lessened blood flow, might be present for a long time but are not evident because of cognitive reserve, a phenomenon where other areas of the brain compensate for deficits in one region. Early detection of cognitive decline is vital, because treatments for Alzheimer’s disease (AD), the most common type of dementia, are most effective in this early phase.

Researchers recently examined arterial spin labeling (ASL), a new MRI technique that measures brain perfusion and does not require the injection of a contrast agent. “ASL MRI is simple to perform, doesn’t require special equipment and only adds a few minutes to the exam,” said study author Sven Haller, MD, from the University of Geneva (Geneva, Switzerland). The findings were published online October 2014 in the journal Radiology.

The study group included 148 healthy elderly study participants and 65 individuals with mild cognitive impairment (MCI). The participants underwent brain MRI and a neuropsychologic evaluation, a typical battery of tests used to determine cognitive ability. Of the 148 healthy individuals, 75 remained stable, while 73 worsened cognitively at 18 months clinical follow-up. Those who deteriorated had shown reduced perfusion at their baseline ASL MRI scans, especially in the posterior cingulate cortex, an area in the middle of the brain that is associated with the default mode network, the neural network that is active when the brain is not concentrating on a specific task. Declines in this network are seen in MCI patients and are more pronounced in those with Alzheimer’s disease (AD).

The pattern of diminished perfusion in the brains of healthy individuals who went on to develop cognitive deficits was similar to that of patients with MCI. “There is a known close link between neural activity and brain perfusion in the posterior cingulate cortex,” Dr. Haller said. “Less perfusion indicates decreased neural activity.”

The study findings suggest that individuals with decreased perfusion identified with ASL MRI may temporarily maintain their cognitive status through the mobilization of their cognitive reserve, but will ultimately develop slight cognitive deficits.

Previous research conducted with positron emission tomography (PET) imaging, the current gold standard for brain metabolism imaging, revealed that patients with AD had decreased metabolism in the same area of the brain where the perfusion abnormalities were found using ASL MRI. This is evidence of a close association between brain metabolism and perfusion, according to Dr. Haller.

ASL MRI has potential as a standalone test or as an adjunct to PET for dementia screening, Dr. Haller said. While PET can identify markers of AD in the brain and cerebrospinal fluid, it exposes the patient to radiation. ASL does not expose the patient to radiation and is easy to perform in routine clinical settings. “ASL might replace the classic yet unspecific fluordesoxyglucose PET that measures brain metabolism. Instead, PET could be done with the new and specific amyloid PET tracers,” Dr. Haller said.

The findings also support a role for ASL MRI as an alternative to neuropsychologic testing, according to the researchers. They plan to perform follow-up research on the patient group to learn more about ASL and long-term cognitive changes.

Related Links:

University of Geneva


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Wireless Handheld Ultrasound System
TE Air
New
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Breast Imaging Workstation
SecurView

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.